Back to today’s briefing

Story perspectives

New Jersey Leads $39.1M Settlement Against Drug Price Inflators

3/30/2025

36 8

Summary

Story summary

New Jersey and a coalition of states are pushing for a $39.1 million settlement with Apotex, accused of inflating prices and stifling competition for generic drugs. Consumers who bought specific medications between May 2009 and December 2019 could receive compensation, while Apotex and Heritage Pharmaceuticals commit to reforms to uphold antitrust laws.

1 of 1

Story summary

New Jersey and a coalition of states are pushing for a $39.1 million settlement with Apotex, accused of inflating prices and stifling competition for generic drugs. Consumers who bought specific medications between May 2009 and December 2019 could receive compensation, while Apotex and Heritage Pharmaceuticals commit to reforms to uphold antitrust laws.